Patents by Inventor Andreas Greinacher

Andreas Greinacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HEPARIN-INDUCED THROMBOCYTOPENIA ASSAY
    Publication number: 20190346440
    Abstract: Disclosed herein are methods and kits for identifying platelet activating anti-PF4/P antibodies in a biological sample useful in diagnosing heparin-induced thrombocytopenia (HIT).
    Type: Application
    Filed: April 18, 2019
    Publication date: November 14, 2019
    Applicant: BIOKIT RESEARCH & DEVELOPMENTS, S.L.U.
    Inventors: Andreas Greinacher, Thi Huong Nguyen
  • Screening methods for transfusion related acute lung injury (TRALI)
    Patent number: 9963741
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: May 8, 2018
    Assignees: ERNST-MORITZ-ARNDT-UNIVERSITÄT GREIFSWALD, DRK BLUTSPENDEDIENST WEST GMBH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Screening Methods for Transfusion Related Acute Lung Injury (TRALI)
    Publication number: 20150203915
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence.
    Type: Application
    Filed: April 3, 2015
    Publication date: July 23, 2015
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Screening methods for transfusion related acute lung injury (TRALI)
    Patent number: 8999651
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: April 7, 2015
    Assignees: Ernst-Moritz-Arndt-Universität Greifswald, DRK Blutspendedienst West GmbH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Screening Methods for Transfusion Related Acute Lung Injury (TRALI)
    Publication number: 20130189696
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence.
    Type: Application
    Filed: March 18, 2013
    Publication date: July 25, 2013
    Applicants: DRK BLUTSPENDEDIENST WEST GMBH, ERNST-MORITZ-ARNDT-UNIVERSITAT GREIFSWALD
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Screening methods for transfusion related acute lung injury
    Patent number: 8435733
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
    Type: Grant
    Filed: November 29, 2011
    Date of Patent: May 7, 2013
    Assignees: Ernst-Moritz-Arndt-Universität Greifswald, DRK Blutspendedienst West GmbH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Screening Methods for Transfusion Related Acute Lung Injury
    Publication number: 20120070834
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
    Type: Application
    Filed: November 29, 2011
    Publication date: March 22, 2012
    Applicants: DRK BLUTSPENDIENST WEST GMBH, ERNST-MORITZ-ARNDT-UNIVERSITÄT GREIFSWALD
    Inventors: ANDREAS GREINACHER, JAN WESCHE, JUERGEN BUX, ANGELIKA REIL
  • Screening methods for transfusion related acute lung injury (TRALI)
    Patent number: 8084216
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence. This invention provides methods and kits for screening for HNA-3a and HNA-3b specific antibodies, HNA-3a and HNA-3b polypeptides and HNA-3a and HNA-3b nucleic acids in a sample of a biological tissue intended for transplantation.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: December 27, 2011
    Assignees: Ernst-Moritz-Arndt-Universität Greifswald, DRK Blutspendedienst West GmbH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Screening Methods for Transfusion Related Acute Lung Injury (TRALI)
    Publication number: 20100055706
    Abstract: The invention relates to the discovery that HNA-3a and HNA-3b are antigens within a polypeptide sequence that is highly similar to the CTL2 amino acid sequence.
    Type: Application
    Filed: September 3, 2009
    Publication date: March 4, 2010
    Applicants: ERNST-MORITZ-ARNDT-UNIVERSITAT GREIFSWALD, DRK BLUTSPENDEDIENST WEST GMBH
    Inventors: Andreas Greinacher, Jan Wesche, Juergen Bux, Angelika Reil
  • Use Of Mrp4-Inhibitors For The Treatment And/Or Prophylaxis Of Cardiovascular Diseases
    Publication number: 20070212366
    Abstract: The invention relates to the use of inhibitors of the multidrug resistance protein 4 (MRP4) in thrombocytes for the treatment and/or prophylaxis of cardiovascular diseases.
    Type: Application
    Filed: November 5, 2004
    Publication date: September 13, 2007
    Applicant: ERNST-MORITZ-ARNDT-UNIVERSITAT GREIFSWALD
    Inventors: Andreas Greinacher, Heyo Kroemer, Gabriele Jedlitschky
  • Wristwatch
    Patent number: D434677
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: December 5, 2000
    Inventor: Andreas Greinacher